| 发明名称 |
ADJUVANT SYSTEM FOR ORAL VACCINE ADMINISTRATION |
| 摘要 |
The present invention provides adjuvant compositions that have improved stability, increased potency and which provide an enhanced Th1 response and wherein the compositions can be administered orally. The present invention also provides methods of making those compositions and administration of the improved adjuvant compositions. |
| 申请公布号 |
US2015079130(A1) |
申请公布日期 |
2015.03.19 |
| 申请号 |
US201313261964 |
申请日期 |
2013.04.03 |
| 申请人 |
Vaxform, LLC |
发明人 |
Morefield Garry L. |
| 分类号 |
A61K39/39;A61K31/70;A61K39/09 |
主分类号 |
A61K39/39 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. An immunological composition for oral administration comprising one or more C-type lectin (CTL) receptor ligands, one or more aluminum adjuvants and one or more antigens and one or more polymers. |
| 地址 |
Lehigh Valley PA US |
